Intriguingly, MDH2 transcript levels in breast cancer patients were strongly correlated with various clinicopathological features, including breast cancer subtype, pathological T stage, HER2 status, ER status, PR status, race, and histological type. Here, ERBB2 is linked to breast carcinoma.